Ulcerative colitis

July 5, 2016July 5, 2016

Regular Yoga Practice Seen to Ease Disease Activity in Ulcerative Colitis Patients

News, Ulcerative colitis

Ulcerative colitis patients who practiced hatha yoga for 12 weeks experienced reductions in disease activity and saw significant improvements in their quality of life and mental health, according to a ... Read more

June 30, 2016June 30, 2016

Inflammation Due to Ulcerative Colitis Treated by IL-7 Receptor Antagonist in Early Study

News, Ulcerative colitis

OSE Immunotherapeutics announced that its interleukin-7 (IL-7) receptor agonist, Effi-7, an immunomodulatory drug being developed for patients with ulcerative colitis, showed positive pre-clinical results. The findings were recently presented at the Federation of Clinical ... Read more

June 21, 2016June 21, 2016

Cellceutix Begins Phase 2 Trial of Ulcerative Proctitis Drug Candidate Brilacidin

Crohn's Disease, IBD News, News, Ulcerative colitis

Cellceutix recently began screening participants and administering therapy for its Phase 2 trial assessing the drug candidate Brilacidin for the treatment of ulcerative proctitis, a mild form of ulcerative colitis. The causes for ... Read more

June 14, 2016June 14, 2016

Theravance Reports Positive Phase 1 Data on TD-1473, a JAK Inhibitor for IBD

IBD News, News, Ulcerative colitis

Theravance Biopharma, Inc., recently reported positive data from its Phase 1 clinical trial assessing TD-1473, a new and oral pan-Janus kinase (JAK) inhibitor designed to enter the gastrointestinal tract and target inflammation without significant ... Read more

June 9, 2016August 12, 2016

IBD Study Shows Celltrion’s Inflectra, Biosimilar of Infliximab, Is Safe and Effective

Crohn's Disease, IBD News, News, Ulcerative colitis

Celltrion’s Inflectra, a biosimilar version of infliximab (Remicade), is both safe and effective in patients with inflammatory bowel disease (IBD), a recent study reported at the Digestive Disease Week 2016 meeting ... Read more

May 31, 2016May 31, 2016

Two Variants of a Gut Protein Seen to Have Opposite Roles in Colitis and Colon Cancer Risk

Colon Cancer, IBD News, News, Ulcerative colitis

A team of researchers at the University of California, Riverside, found that a tight control of the levels of two forms of the same protein, hepatocyte nuclear factor 4-alpha (HNF4-α), is critical ... Read more

May 26, 2016May 26, 2016

AbbVie Showcases IBD Therapies at Digestive Disease Week Annual Meeting

Crohn's Disease, IBD News, News, Ulcerative colitis

North Chicago, Illinois based multinational biopharmaceutical company AbbVie presented 13 abstracts at the Digestive Disease Week (DDW) Annual Meeting held May 21-24, 2016, at San Diego, California. Abstracts presented addressed ... Read more

May 17, 2016May 17, 2016

Risk of Developing IBD Can Be Predicted with Serum Biomarkers, Researchers Find

Crohn's Disease, IBD News, News, Ulcerative colitis

Findings from the PREDICTS study indicated that before symptoms appear, markers of Crohn’s disease can be detected. The new discovery may help to predict risk not only of disease development but ... Read more

May 12, 2016May 12, 2016

Colon Health Linked in Study to Production of Sugars Known as O-glycans

Colon Cancer, Crohn's Disease, IBD News, News, Ulcerative colitis

Certain sugars produced by the body, called O-glycans, may play a crucial role in keeping the colon healthy and in preventing cancer. Understanding how these sugars function to protect the colon ... Read more

April 22, 2016April 22, 2016

Worm Infection Reduces Risk of Inflammatory Bowel Disease by Modifying Intestinal Bacteria Content, Study Finds

Crohn's Disease, IBD News, News, Ulcerative colitis

Parasitic worms may trigger immune responses that alter the bacterial balance in the gut, preventing the development of inflammatory bowel diseases (IBD) such as Crohn’s disease. The study, “Helminth infection promotes ... Read more